Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study

The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene Akt has been reported to regulate proliferation and apoptosis in several tissues but there are no data on the involvement of Akt in oesophageal carcinogene...

Full description

Saved in:
Bibliographic Details
Published inBMC cancer Vol. 7; no. 1; p. 97
Main Authors Beales, Ian L P, Ogunwobi, Olorunseun, Cameron, Ewen, El-Amin, Khalid, Mutungi, Gabriel, Wilkinson, Mark
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 08.06.2007
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene Akt has been reported to regulate proliferation and apoptosis in several tissues but there are no data on the involvement of Akt in oesophageal carcinogenesis. Therefore we have examined the activation of Akt in Barrett's oesophagus and oesophageal adenocarcinoma and the functional effects of Akt activation in vitro. Expression of total and active (phosphorylated) Akt were determined in endoscopic biopsies and surgical resection specimens using immunohistochemistry. The functional effects of Akt were examined using Barrett's adenocarcinoma cells in culture. In normal squamous oesophagus, erosive oesophagitis and non-dysplastic Barrett's oesophagus, phospho-Akt was limited to the basal 1/3 of the mucosa. Image analysis confirmed that Akt activation was significantly increased in non-dysplastic Barrett's oesophagus compared to squamous epithelium and further significantly increased in high-grade dysplasia and adenocarcinoma. In all cases of high grade dysplasia and adenocarcinoma Akt was activated in the luminal 1/3 of the epithelium. Transient acid exposure and the obesity hormone leptin activated Akt, stimulated proliferation and inhibited apoptosis: the combination of acid and leptin was synergistic. Inhibition of Akt phosphorylation with LY294002 increased apoptosis and blocked the effects of acid and leptin both alone and in combination. Activation of Akt was associated with downstream phosphorylation and deactivation of the pro-apoptotic protein Bad and phosphorylation of the Forkhead family transcription factor FOXO1. Akt is abnormally activated in Barrett's oesophagus, high grade dysplasia and adenocarcinoma. Akt activation promotes proliferation and inhibits apoptosis in Barrett's adenocarcinoma cells and both transient acid exposure and leptin stimulate Akt phosphorylation. Downstream targets of Akt include Bad and Forkhead transcription factors. Activation of Akt in obesity and by reflux of gastric acid may be important in the pathogenesis of Barrett's adenocarcinoma.
AbstractList The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene Akt has been reported to regulate proliferation and apoptosis in several tissues but there are no data on the involvement of Akt in oesophageal carcinogenesis. Therefore we have examined the activation of Akt in Barrett's oesophagus and oesophageal adenocarcinoma and the functional effects of Akt activation in vitro. Expression of total and active (phosphorylated) Akt were determined in endoscopic biopsies and surgical resection specimens using immunohistochemistry. The functional effects of Akt were examined using Barrett's adenocarcinoma cells in culture. In normal squamous oesophagus, erosive oesophagitis and non-dysplastic Barrett's oesophagus, phospho-Akt was limited to the basal 1/3 of the mucosa. Image analysis confirmed that Akt activation was significantly increased in non-dysplastic Barrett's oesophagus compared to squamous epithelium and further significantly increased in high-grade dysplasia and adenocarcinoma. In all cases of high grade dysplasia and adenocarcinoma Akt was activated in the luminal 1/3 of the epithelium. Transient acid exposure and the obesity hormone leptin activated Akt, stimulated proliferation and inhibited apoptosis: the combination of acid and leptin was synergistic. Inhibition of Akt phosphorylation with LY294002 increased apoptosis and blocked the effects of acid and leptin both alone and in combination. Activation of Akt was associated with downstream phosphorylation and deactivation of the pro-apoptotic protein Bad and phosphorylation of the Forkhead family transcription factor FOXO1. Akt is abnormally activated in Barrett's oesophagus, high grade dysplasia and adenocarcinoma. Akt activation promotes proliferation and inhibits apoptosis in Barrett's adenocarcinoma cells and both transient acid exposure and leptin stimulate Akt phosphorylation. Downstream targets of Akt include Bad and Forkhead transcription factors. Activation of Akt in obesity and by reflux of gastric acid may be important in the pathogenesis of Barrett's adenocarcinoma.
BACKGROUND: The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene Akt has been reported to regulate proliferation and apoptosis in several tissues but there are no data on the involvement of Akt in oesophageal carcinogenesis. Therefore we have examined the activation of Akt in Barrett's oesophagus and oesophageal adenocarcinoma and the functional effects of Akt activation in vitro. METHODS: Expression of total and active (phosphorylated) Akt were determined in endoscopic biopsies and surgical resection specimens using immunohistochemistry. The functional effects of Akt were examined using Barrett's adenocarcinoma cells in culture. RESULTS: In normal squamous oesophagus, erosive oesophagitis and non-dysplastic Barrett's oesophagus, phospho-Akt was limited to the basal 1/3 of the mucosa. Image analysis confirmed that Akt activation was significantly increased in non-dysplastic Barrett's oesophagus compared to squamous epithelium and further significantly increased in high-grade dysplasia and adenocarcinoma. In all cases of high grade dysplasia and adenocarcinoma Akt was activated in the luminal 1/3 of the epithelium. Transient acid exposure and the obesity hormone leptin activated Akt, stimulated proliferation and inhibited apoptosis: the combination of acid and leptin was synergistic. Inhibition of Akt phosphorylation with LY294002 increased apoptosis and blocked the effects of acid and leptin both alone and in combination. Activation of Akt was associated with downstream phosphorylation and deactivation of the pro-apoptotic protein Bad and phosphorylation of the Forkhead family transcription factor FOXO1. CONCLUSION: Akt is abnormally activated in Barrett's oesophagus, high grade dysplasia and adenocarcinoma. Akt activation promotes proliferation and inhibits apoptosis in Barrett's adenocarcinoma cells and both transient acid exposure and leptin stimulate Akt phosphorylation. Downstream targets of Akt include Bad and Forkhead transcription factors. Activation of Akt in obesity and by reflux of gastric acid may be important in the pathogenesis of Barrett's adenocarcinoma
Abstract Background The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene Akt has been reported to regulate proliferation and apoptosis in several tissues but there are no data on the involvement of Akt in oesophageal carcinogenesis. Therefore we have examined the activation of Akt in Barrett's oesophagus and oesophageal adenocarcinoma and the functional effects of Akt activation in vitro. Methods Expression of total and active (phosphorylated) Akt were determined in endoscopic biopsies and surgical resection specimens using immunohistochemistry. The functional effects of Akt were examined using Barrett's adenocarcinoma cells in culture. Results In normal squamous oesophagus, erosive oesophagitis and non-dysplastic Barrett's oesophagus, phospho-Akt was limited to the basal 1/3 of the mucosa. Image analysis confirmed that Akt activation was significantly increased in non-dysplastic Barrett's oesophagus compared to squamous epithelium and further significantly increased in high-grade dysplasia and adenocarcinoma. In all cases of high grade dysplasia and adenocarcinoma Akt was activated in the luminal 1/3 of the epithelium. Transient acid exposure and the obesity hormone leptin activated Akt, stimulated proliferation and inhibited apoptosis: the combination of acid and leptin was synergistic. Inhibition of Akt phosphorylation with LY294002 increased apoptosis and blocked the effects of acid and leptin both alone and in combination. Activation of Akt was associated with downstream phosphorylation and deactivation of the pro-apoptotic protein Bad and phosphorylation of the Forkhead family transcription factor FOXO1. Conclusion Akt is abnormally activated in Barrett's oesophagus, high grade dysplasia and adenocarcinoma. Akt activation promotes proliferation and inhibits apoptosis in Barrett's adenocarcinoma cells and both transient acid exposure and leptin stimulate Akt phosphorylation. Downstream targets of Akt include Bad and Forkhead transcription factors. Activation of Akt in obesity and by reflux of gastric acid may be important in the pathogenesis of Barrett's adenocarcinoma
ArticleNumber 97
Audience Academic
Author Ogunwobi, Olorunseun
El-Amin, Khalid
Wilkinson, Mark
Cameron, Ewen
Beales, Ian L P
Mutungi, Gabriel
AuthorAffiliation 3 Department of Histopathology, Norfolk and Norwich University Hospital, Norwich, NR4 7UZ, UK
2 Department of Cell Biology and Physiology, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, NR4 7TJ, UK
1 Gastroenterology Unit, Norfolk and Norwich University Hospital, Norwich, NR4 7UZ, UK
AuthorAffiliation_xml – name: 3 Department of Histopathology, Norfolk and Norwich University Hospital, Norwich, NR4 7UZ, UK
– name: 2 Department of Cell Biology and Physiology, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, NR4 7TJ, UK
– name: 1 Gastroenterology Unit, Norfolk and Norwich University Hospital, Norwich, NR4 7UZ, UK
Author_xml – sequence: 1
  givenname: Ian L P
  surname: Beales
  fullname: Beales, Ian L P
  email: ian.beales@nnuh.nhs.uk
  organization: Gastroenterology Unit, Norfolk and Norwich University Hospital, Norwich, UK. ian.beales@nnuh.nhs.uk
– sequence: 2
  givenname: Olorunseun
  surname: Ogunwobi
  fullname: Ogunwobi, Olorunseun
– sequence: 3
  givenname: Ewen
  surname: Cameron
  fullname: Cameron, Ewen
– sequence: 4
  givenname: Khalid
  surname: El-Amin
  fullname: El-Amin, Khalid
– sequence: 5
  givenname: Gabriel
  surname: Mutungi
  fullname: Mutungi, Gabriel
– sequence: 6
  givenname: Mark
  surname: Wilkinson
  fullname: Wilkinson, Mark
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17559672$$D View this record in MEDLINE/PubMed
BookMark eNp1k0tv1DAQgCNURB9w5YgsIYE4pNh52DEHpKXiUakSEo-zNXHGG5dsnNpOxf5G_hRJt5SNKMohzvibL2N7fJwc9K7HJHnK6CljFX_NCsHSrKAiFakUD5Kju8DB3vgwOQ7hklImKlo9Sg6ZKEvJRXaU_FrpaK8hWtcTZ8jqRyQ2ENtrjxCwmUYktkiabRg6CBZSDV7b3m2ABLwasdc4M-_Ae4zxZSAOgxtaWI-BQN8Q7frobT1GDCS6PfHgXWcN-t2vZ9T2ra3tn0pgcEN0wYY3BEhrQ3QDxNZ1bm01dDcJZuz1jE-fIY7N9nHy0EAX8Mnt-yT5_uH9t7NP6cXnj-dnq4u05kURU1FmRjBGM2QGNGgBOW1MLSrEikvOdJnXVIAxXOYMacV5JaSRgKjrqgSdnyTnO2_j4FIN3m7Ab5UDq24Czq8V-Gh1h0rmWkJdUqhEUzR5AWXJBBclLzTIjPLJ9XbnGsZ6g43GabugW0iXM71t1dpdK1ZJWVI5CVY7QW3dfwTLGe02am4MNTeGEkqKyfF851jDVLPtjZtIvbFBqxXjJecyk9lEnd5DTU-DGzudMxo7xRcJrxYJcy_gz7iGMQR1_vXLkn2xx7YIXWyD68b5fMO9VWjvQvBo7pbKqJqvxL-Le7a_w3_x2zuQ_wazyA10
CitedBy_id crossref_primary_10_1038_s41598_020_69708_2
crossref_primary_10_1111_dote_12210
crossref_primary_10_12659_MSM_898131
crossref_primary_10_1111_j_1572_0241_2007_01773_x
crossref_primary_10_18632_oncotarget_8777
crossref_primary_10_1016_j_mce_2008_01_023
crossref_primary_10_1007_s10147_020_01772_0
crossref_primary_10_1007_s10620_011_1899_0
crossref_primary_10_1007_s10620_008_0294_y
crossref_primary_10_3892_ol_2015_3260
crossref_primary_10_1038_oby_2009_508
crossref_primary_10_1002_mnfr_200700513
crossref_primary_10_1177_1756283X14538689
crossref_primary_10_1002_ijc_24875
crossref_primary_10_1016_j_mce_2013_08_013
crossref_primary_10_3390_diagnostics12102437
crossref_primary_10_1007_s10620_015_3869_4
crossref_primary_10_1016_j_mce_2008_08_004
crossref_primary_10_4161_cbt_25362
crossref_primary_10_3390_md17100587
crossref_primary_10_1016_j_gtc_2015_03_001
crossref_primary_10_1111_j_1752_8062_2009_00131_x
crossref_primary_10_3390_ijms241411318
crossref_primary_10_14814_phy2_13683
crossref_primary_10_1016_j_anndiagpath_2007_12_001
crossref_primary_10_1016_j_jtcvs_2009_09_066
crossref_primary_10_1016_j_semcancer_2017_09_009
crossref_primary_10_1007_s11010_021_04067_8
crossref_primary_10_1111_j_1572_0241_2007_01768_x
Cites_doi 10.1056/NEJM199903183401101
10.1016/j.regpep.2005.08.002
10.1136/gut.2004.041558
10.1158/0008-5472.CAN-03-2438
10.1074/jbc.M305063200
10.1016/S0092-8674(00)80595-4
10.1200/JCO.2004.01.103
10.1016/S0092-8674(00)80405-5
10.1074/jbc.M201119200
10.7326/0003-4819-130-11-199906010-00003
10.1016/j.bbrc.2004.08.059
10.3322/canjclin.55.1.10
10.1006/excr.1999.4690
10.1053/gast.2002.30993
10.1152/ajpgi.00167.2005
10.1053/gast.2003.50091
10.1111/j.1572-0241.1999.01276.x
10.1016/j.lfs.2004.03.041
10.1002/bjs.5530
10.1016/S0016-5107(99)70339-1
10.1093/ajcp/103.3.295
10.1152/ajpgi.00144.2004
10.1172/JCI119018
10.1152/ajpgi.00543.2001
10.1038/sj.bjc.6602028
10.1111/j.1572-0241.2002.05767.x
10.1074/jbc.M312999200
10.1136/gut.2004.041566
10.1053/j.gastro.2005.03.077
10.1054/bjoc.2000.1660
10.1016/j.mce.2005.12.050
10.1016/j.jss.2005.03.013
10.1056/NEJM199602013340503
10.1111/j.1572-0241.2002.05768.x
10.1210/en.2006-0224
10.1152/ajpgi.2001.280.2.G298
10.1093/jnci/djg047
10.1038/ncpgasthep0057
10.1152/ajpgi.00215.2005
10.1053/gast.1996.v111.pm8698230
10.1007/s00384-006-0181-y
10.1158/0008-5472.CAN-03-2713
10.1136/gut.52.2.174
10.1016/S0022-4804(03)00166-5
10.1074/jbc.274.24.16741
ContentType Journal Article
Copyright COPYRIGHT 2007 BioMed Central Ltd.
Copyright © 2007 Beales et al; licensee BioMed Central Ltd. 2007 Beales et al; licensee BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2007 BioMed Central Ltd.
– notice: Copyright © 2007 Beales et al; licensee BioMed Central Ltd. 2007 Beales et al; licensee BioMed Central Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ISR
5PM
DOA
DOI 10.1186/1471-2407-7-97
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Gale In Context: Science
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2407
EndPage 97
ExternalDocumentID oai_doaj_org_article_93c9ab50a87d4d34a551767564ca9206
oai_biomedcentral_com_1471_2407_7_97
A165669292
10_1186_1471_2407_7_97
17559672
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United Kingdom
GeographicLocations_xml – name: United Kingdom
GroupedDBID ---
-A0
0R~
23N
2VQ
2WC
4.4
53G
5VS
6J9
6PF
AAFWJ
AAJSJ
AAWTL
ABDBF
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFPKN
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
C1A
C24
C6C
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
ESX
F5P
GROUPED_DOAJ
GX1
H13
HYE
IAO
IHR
IHW
INH
INR
IPNFZ
ISR
ITC
KQ8
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
RBZ
RIG
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
W2D
WOQ
WOW
XSB
AAYXX
CITATION
AFGXO
7X7
ABVAZ
AFNRJ
5PM
ID FETCH-LOGICAL-b644t-752f71102e1facac7a30dfb78ee86961c53b07aff6931e0866879f9aeecb85ac3
IEDL.DBID RPM
ISSN 1471-2407
IngestDate Tue Oct 22 14:38:39 EDT 2024
Tue Sep 17 21:20:31 EDT 2024
Wed May 22 07:11:46 EDT 2024
Fri Feb 23 00:21:15 EST 2024
Wed Nov 13 00:01:31 EST 2024
Sat Sep 28 21:19:12 EDT 2024
Tue Aug 20 22:06:22 EDT 2024
Thu Sep 12 17:47:22 EDT 2024
Sat Sep 28 07:48:17 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b644t-752f71102e1facac7a30dfb78ee86961c53b07aff6931e0866879f9aeecb85ac3
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1899509/
PMID 17559672
ParticipantIDs doaj_primary_oai_doaj_org_article_93c9ab50a87d4d34a551767564ca9206
pubmedcentral_primary_oai_pubmedcentral_nih_gov_1899509
biomedcentral_primary_oai_biomedcentral_com_1471_2407_7_97
gale_infotracmisc_A165669292
gale_infotracacademiconefile_A165669292
gale_incontextgauss_ISR_A165669292
gale_healthsolutions_A165669292
crossref_primary_10_1186_1471_2407_7_97
pubmed_primary_17559672
PublicationCentury 2000
PublicationDate 2007-06-08
PublicationDateYYYYMMDD 2007-06-08
PublicationDate_xml – month: 06
  year: 2007
  text: 2007-06-08
  day: 08
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC cancer
PublicationTitleAlternate BMC Cancer
PublicationYear 2007
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 10102273 - Cell. 1999 Mar 19;96(6):857-68
16169610 - Regul Pept. 2006 Mar 15;134(1):1-8
10579924 - Exp Cell Res. 1999 Nov 25;253(1):210-29
15887129 - Gastroenterology. 2005 May;128(5):1471-505
12094844 - Am J Gastroenterol. 2002 Jun;97(6):1319-27
12943810 - J Surg Res. 2003 Jul;113(1):50-5
16265072 - Nat Clin Pract Gastroenterol Hepatol. 2004 Dec;1(2):106-12
12612900 - Gastroenterology. 2003 Mar;124(3):615-25
15026323 - Cancer Res. 2004 Mar 15;64(6):1915-9
10445526 - Am J Gastroenterol. 1999 Aug;94(8):2043-53
15964304 - J Surg Res. 2005 Jul 1;127(1):53-8
13130116 - J Natl Cancer Inst. 2003 Sep 17;95(18):1404-13
15483033 - J Clin Oncol. 2004 Oct 15;22(20):4217-26
11259087 - Br J Cancer. 2001 Mar 23;84(6):748-53
15351698 - Biochem Biophys Res Commun. 2004 Oct 8;323(1):44-8
8903332 - J Clin Invest. 1996 Nov 1;98(9):2120-8
10080844 - N Engl J Med. 1999 Mar 18;340(11):825-31
12094845 - Am J Gastroenterol. 2002 Jun;97(6):1328-31
16912864 - Int J Colorectal Dis. 2007 Apr;22(4):401-9
12000750 - J Biol Chem. 2002 Aug 2;277(31):27613-21
14996709 - Cancer Res. 2004 Mar 1;64(5):1561-9
17212381 - Br J Surg. 2007 Mar;94(3):346-54
11832445 - Gastroenterology. 2002 Feb;122(2):299-307
15711005 - Gut. 2005 Mar;54 Suppl 1:i27-32
15661684 - CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30
14752104 - J Biol Chem. 2004 Apr 16;279(16):16495-502
16740977 - Endocrinology. 2006 Sep;147(9):4505-16
15266314 - Br J Cancer. 2004 Aug 16;91(4):714-9
12121879 - Am J Physiol Gastrointest Liver Physiol. 2002 Aug;283(2):G327-34
16239404 - Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G335-42
15474551 - Life Sci. 2004 Nov 5;75(25):2983-95
10375336 - Ann Intern Med. 1999 Jun 1;130(11):883-90
15711004 - Gut. 2005 Mar;54 Suppl 1:i21-6
9346240 - Cell. 1997 Oct 17;91(2):231-41
12826665 - J Biol Chem. 2003 Sep 12;278(37):34783-93
10385717 - Gastrointest Endosc. 1999 Jul;50(1):23-6
12524396 - Gut. 2003 Feb;52(2):174-80
8532024 - N Engl J Med. 1996 Feb 1;334(5):292-5
16081761 - Am J Physiol Gastrointest Liver Physiol. 2005 Dec;289(6):G991-7
10358014 - J Biol Chem. 1999 Jun 11;274(24):16741-6
8698230 - Gastroenterology. 1996 Jul;111(1):85-92
16442704 - Mol Cell Endocrinol. 2006 Mar 9;247(1-2):140-9
15231484 - Am J Physiol Gastrointest Liver Physiol. 2004 Oct;287(4):G743-8
7872251 - Am J Clin Pathol. 1995 Mar;103(3):295-9
11208554 - Am J Physiol Gastrointest Liver Physiol. 2001 Feb;280(2):G298-307
RV Considine (747_CR24) 1996; 334
GH Williams (747_CR38) 2004; 91
BS Kaur (747_CR21) 2002; 283
S Arico (747_CR39) 2002; 277
DT McManus (747_CR9) 2004; 64
ED Tang (747_CR32) 1999; 274
RC Fitzgerald (747_CR3) 2005; 54
MR Hoda (747_CR45) 2007; 94
J Lagergren (747_CR16) 1999; 130
O Ogunwobi (747_CR26) 2006; 147
RF Souza (747_CR23) 2002; 122
JC Harris (747_CR12) 2004; 64
P Somasundar (747_CR27) 2003; 113
JE Thompson (747_CR11) 2004; 22
LS Engel (747_CR19) 2003; 95
D Provenzale (747_CR6) 1999; 94
A Brunet (747_CR31) 1999; 96
IL Beales (747_CR36) 2006; 247
C Tselepis (747_CR15) 2003; 52
K Bodger (747_CR25) 2005; 54
OO Ogunwobi (747_CR35) 2006; 134
MH Kulke (747_CR40) 2001; 84
OO Ogunwobi (747_CR28) 2007; 22
KK Wang (747_CR4) 2005; 128
RF Souza (747_CR41) 2004; 287
KR Geisinger (747_CR37) 1995; 103
P Rouet-Benzineb (747_CR43) 2004; 279
M Alikhan (747_CR5) 1999; 50
IL Beales (747_CR34) 2004; 75
ES Kandel (747_CR10) 1999; 253
K Jaiswal (747_CR42) 2006; 290
A Jemal (747_CR1) 2006; 55
CR Haigh (747_CR13) 2003; 124
L Vona-Davis (747_CR14) 2005; 127
S Ramamoorthy (747_CR46) 2004; 323
CP Caygill (747_CR18) 2002; 97
NJ Shaheen (747_CR8) 2002; 97
JP Spencer (747_CR29) 2003; 278
RC Fitzgerald (747_CR22) 1996; 98
P Sharma (747_CR7) 2005; 54
J Lagergren (747_CR17) 1999; 340
D Armstrong (747_CR33) 1996; 111
GA Sarosi Jr (747_CR20) 2005; 289
SR Datta (747_CR30) 1997; 91
A Todisco (747_CR44) 2001; 280
NS Buttar (747_CR2) 2004; 1
References_xml – volume: 340
  start-page: 825
  year: 1999
  ident: 747_CR17
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199903183401101
  contributor:
    fullname: J Lagergren
– volume: 134
  start-page: 1
  year: 2006
  ident: 747_CR35
  publication-title: Regul Pept
  doi: 10.1016/j.regpep.2005.08.002
  contributor:
    fullname: OO Ogunwobi
– volume: 54
  start-page: i21
  issue: Suppl 1
  year: 2005
  ident: 747_CR3
  publication-title: Gut
  doi: 10.1136/gut.2004.041558
  contributor:
    fullname: RC Fitzgerald
– volume: 64
  start-page: 1561
  year: 2004
  ident: 747_CR9
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-03-2438
  contributor:
    fullname: DT McManus
– volume: 278
  start-page: 34783
  year: 2003
  ident: 747_CR29
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M305063200
  contributor:
    fullname: JP Spencer
– volume: 96
  start-page: 857
  year: 1999
  ident: 747_CR31
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80595-4
  contributor:
    fullname: A Brunet
– volume: 22
  start-page: 4217
  year: 2004
  ident: 747_CR11
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2004.01.103
  contributor:
    fullname: JE Thompson
– volume: 91
  start-page: 231
  year: 1997
  ident: 747_CR30
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80405-5
  contributor:
    fullname: SR Datta
– volume: 277
  start-page: 27613
  year: 2002
  ident: 747_CR39
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M201119200
  contributor:
    fullname: S Arico
– volume: 130
  start-page: 883
  year: 1999
  ident: 747_CR16
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-130-11-199906010-00003
  contributor:
    fullname: J Lagergren
– volume: 323
  start-page: 44
  year: 2004
  ident: 747_CR46
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2004.08.059
  contributor:
    fullname: S Ramamoorthy
– volume: 55
  start-page: 10
  year: 2006
  ident: 747_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/canjclin.55.1.10
  contributor:
    fullname: A Jemal
– volume: 253
  start-page: 210
  year: 1999
  ident: 747_CR10
  publication-title: Exp Cell Res
  doi: 10.1006/excr.1999.4690
  contributor:
    fullname: ES Kandel
– volume: 122
  start-page: 299
  year: 2002
  ident: 747_CR23
  publication-title: Gastroenterology
  doi: 10.1053/gast.2002.30993
  contributor:
    fullname: RF Souza
– volume: 290
  start-page: G335
  year: 2006
  ident: 747_CR42
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00167.2005
  contributor:
    fullname: K Jaiswal
– volume: 124
  start-page: 615
  year: 2003
  ident: 747_CR13
  publication-title: Gastroenterology
  doi: 10.1053/gast.2003.50091
  contributor:
    fullname: CR Haigh
– volume: 94
  start-page: 2043
  year: 1999
  ident: 747_CR6
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.1999.01276.x
  contributor:
    fullname: D Provenzale
– volume: 75
  start-page: 2983
  year: 2004
  ident: 747_CR34
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2004.03.041
  contributor:
    fullname: IL Beales
– volume: 94
  start-page: 346
  year: 2007
  ident: 747_CR45
  publication-title: Br J Surg
  doi: 10.1002/bjs.5530
  contributor:
    fullname: MR Hoda
– volume: 50
  start-page: 23
  year: 1999
  ident: 747_CR5
  publication-title: Gastrointest Endosc
  doi: 10.1016/S0016-5107(99)70339-1
  contributor:
    fullname: M Alikhan
– volume: 103
  start-page: 295
  year: 1995
  ident: 747_CR37
  publication-title: Am J Clin Pathol
  doi: 10.1093/ajcp/103.3.295
  contributor:
    fullname: KR Geisinger
– volume: 287
  start-page: G743
  year: 2004
  ident: 747_CR41
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00144.2004
  contributor:
    fullname: RF Souza
– volume: 98
  start-page: 2120
  year: 1996
  ident: 747_CR22
  publication-title: J Clin Invest
  doi: 10.1172/JCI119018
  contributor:
    fullname: RC Fitzgerald
– volume: 283
  start-page: G327
  year: 2002
  ident: 747_CR21
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00543.2001
  contributor:
    fullname: BS Kaur
– volume: 91
  start-page: 714
  year: 2004
  ident: 747_CR38
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6602028
  contributor:
    fullname: GH Williams
– volume: 97
  start-page: 1319
  year: 2002
  ident: 747_CR8
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2002.05767.x
  contributor:
    fullname: NJ Shaheen
– volume: 279
  start-page: 16495
  year: 2004
  ident: 747_CR43
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M312999200
  contributor:
    fullname: P Rouet-Benzineb
– volume: 54
  start-page: i27
  issue: Suppl 1
  year: 2005
  ident: 747_CR7
  publication-title: Gut
  doi: 10.1136/gut.2004.041566
  contributor:
    fullname: P Sharma
– volume: 128
  start-page: 1471
  year: 2005
  ident: 747_CR4
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.03.077
  contributor:
    fullname: KK Wang
– volume: 84
  start-page: 748
  year: 2001
  ident: 747_CR40
  publication-title: Br J Cancer
  doi: 10.1054/bjoc.2000.1660
  contributor:
    fullname: MH Kulke
– volume: 247
  start-page: 140
  year: 2006
  ident: 747_CR36
  publication-title: Mol Cell Endocrinol
  doi: 10.1016/j.mce.2005.12.050
  contributor:
    fullname: IL Beales
– volume: 127
  start-page: 53
  year: 2005
  ident: 747_CR14
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2005.03.013
  contributor:
    fullname: L Vona-Davis
– volume: 334
  start-page: 292
  year: 1996
  ident: 747_CR24
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199602013340503
  contributor:
    fullname: RV Considine
– volume: 97
  start-page: 1328
  year: 2002
  ident: 747_CR18
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2002.05768.x
  contributor:
    fullname: CP Caygill
– volume: 147
  start-page: 4505
  year: 2006
  ident: 747_CR26
  publication-title: Endocrinology
  doi: 10.1210/en.2006-0224
  contributor:
    fullname: O Ogunwobi
– volume: 280
  start-page: G298
  year: 2001
  ident: 747_CR44
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.2001.280.2.G298
  contributor:
    fullname: A Todisco
– volume: 95
  start-page: 1404
  year: 2003
  ident: 747_CR19
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djg047
  contributor:
    fullname: LS Engel
– volume: 54
  start-page: A70
  issue: Suppl VII
  year: 2005
  ident: 747_CR25
  publication-title: Gut
  contributor:
    fullname: K Bodger
– volume: 1
  start-page: 106
  year: 2004
  ident: 747_CR2
  publication-title: Nat Clin Pract Gastroenterol Hepatol
  doi: 10.1038/ncpgasthep0057
  contributor:
    fullname: NS Buttar
– volume: 289
  start-page: G991
  year: 2005
  ident: 747_CR20
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00215.2005
  contributor:
    fullname: GA Sarosi Jr
– volume: 111
  start-page: 85
  year: 1996
  ident: 747_CR33
  publication-title: Gastroenterology
  doi: 10.1053/gast.1996.v111.pm8698230
  contributor:
    fullname: D Armstrong
– volume: 22
  start-page: 401
  year: 2007
  ident: 747_CR28
  publication-title: Int J Colorectal Dis
  doi: 10.1007/s00384-006-0181-y
  contributor:
    fullname: OO Ogunwobi
– volume: 64
  start-page: 1915
  year: 2004
  ident: 747_CR12
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-03-2713
  contributor:
    fullname: JC Harris
– volume: 52
  start-page: 174
  year: 2003
  ident: 747_CR15
  publication-title: Gut
  doi: 10.1136/gut.52.2.174
  contributor:
    fullname: C Tselepis
– volume: 113
  start-page: 50
  year: 2003
  ident: 747_CR27
  publication-title: J Surg Res
  doi: 10.1016/S0022-4804(03)00166-5
  contributor:
    fullname: P Somasundar
– volume: 274
  start-page: 16741
  year: 1999
  ident: 747_CR32
  publication-title: J Biol Chem
  doi: 10.1074/jbc.274.24.16741
  contributor:
    fullname: ED Tang
SSID ssj0017808
Score 2.0719628
Snippet The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene Akt has been...
BACKGROUND: The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and proto-oncogene...
Abstract Background The incidence of oesophageal adenocarcinoma is increasing rapidly in the developed world. The serine-threonine protein kinase and...
SourceID doaj
pubmedcentral
biomedcentral
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 97
SubjectTerms Adenocarcinoma - enzymology
Adenocarcinoma - pathology
Apoptosis
Barrett Esophagus - enzymology
Barrett Esophagus - pathology
Barrett's esophagus
Cancer
Carcinoma
Cell Proliferation
Cell Transformation, Neoplastic - metabolism
Dysplasia
Enzyme Activation - physiology
Esophageal Neoplasms - enzymology
Esophageal Neoplasms - pathology
Genetic aspects
Humans
Image Processing, Computer-Assisted
Immunohistochemistry
Physiological aspects
Precancerous Conditions - enzymology
Precancerous Conditions - pathology
Protein kinases
Proto-Oncogene Proteins c-akt - metabolism
SummonAdditionalLinks – databaseName: BiomedCentral
  dbid: RBZ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSIgL4s1CAQsh7SkiTz9620VUBakcgEoVF8tx7DYqJBHJHviN_ClmnEfr9shtFY-jdWZsf-MZf0PIu1hUrjCA3KRMXYSBs0gLZyJRVLzIHcu4rxl5_IUdneSfT4vTy_OOaxH8RLD3CSyfGAPgEY8kv03upEiogn759scSL-DC155bZCd6xpv9r91r_xlsR561f1mblx0pzJa8sv0cPiD3J9xIN6OiH5JbtnlE7h5PkfHH5O_GzIXKaOvo5mKgdU_rBkFhbyv4RQHq0epP3_mLk5HBIkJN-0vTOZsaZbZj5u66p63FAgf6bNdT3VTUp7RjbSzb06G98uIOy_44OxqSF62b87qs53-iu7Yb2r7uD6imnt0YiyDPS67vgHvreCRJPdvtE3Jy-PH7h6NoKtQQlQCnhogXqeOAI1KbOG204TqLK1dyYa1gkiWmyMqYa-eYzBILThQTXDqprTWlKLTJnpK9pm3sc0KToooriScypcgdoAmewW6iMfxZWl3oFTkI9Ke6kZRDIU122AIzVqHyFSpfcSX5iqxnZS_9vBMk2A3JLdpC8Hb_ACxTTXNaycxIXRaxFrzKqyzXgD6RG4flRsMQ2Iq8QUtS443WZSlRG2Q8YoBL0xV56yWQiKPBTJ8zvet79enb10BoPQm5FgYG33e8OAEfDLm7Asn9QBJWChM0Pxst-XLwHBxKxqGFBzYejDtsaepzT0KegKMOYPPF_-jjJbk3p1_GYp_sDb939hVgvKF87af3P424UtA
  priority: 500
  providerName: BioMedCentral
– databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLojwXClgIaU9Rk0386m2LqApSOQCVerMcx24jIIlI9tDfyJ9ixnmwFgcu3KJ4EsX2ZB72-PsIeZvKyjMLkZtSG5_gxllipLeJZJVghee5CJyRF5_4-WXx8Ypd7VF9YU3YCA88Dtyxyq0yJUuNFFVR5YUBF48AJLywRm0msO1UzcnUtH8gZOCiy8D04v6BmOAaM8mPl3uJSBDqKTrn_j1yTwHFf7HVi4eKqyf33NHZA3J_iiPpdvz-Q3LHNQ_J3Ytpp_wR-bW1M3EZbT3dfhto3dO6wSCxdxVcUQj9aHXbd-EgZWKRVKhpfxg6V1ejzOlYybvuaeuQ8MBc73pqmoqGEnfkynI9Hdq9F3dIA-TdqFhBtG5u6rKev8R0bTe0fd2fUEMD2jGSIs8mODyAvnZcoqQB_fYxuTx7__XdeTIRNyQlhFdDItjGC4grNi7zxhorTJ5WvhTSOckVzyzLy1QY77nKMwdJFZdCeWWcs6VkxuZPyEHTNu4ZoRmr0krhCk0pCw_RhcjBuxjcDi2dYWZFTqL5090I0qERNjtugT9Y4-RrnHwttBIrsp4ne3kuJEWS_yV5iroQvT3cAFXVk6rqf6nqirxGTdLjCdfFtOgtIiBxiFM3K_ImSCAwR4OVP9dm1_f6w5fPkdB6EvItdAzGdzxIAQOGWF6R5FEkCZbDRs1PR03-03kBCSYX0CIiHY_6Hbc09U0AJc8gcYfg8_n_GKgX5N5clpnKI3Iw_Ny5lxD7DeWr8Jv_BmYNWeI
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELZgSIgXxG8KAyyE1KdA0iS2MwmhDjENpPEAVNqb5Th2FzGSUqcS-xv5p7hzknZmPPJWxeeotu_s73Ln7wh5FYvK5hqQW1HMbISBs0gJqyORVzzPLEu5rxl58pkdL7JPp_npLv9pmED3T9cO60kt1uevf_28eAcG_9YbvGBvEthgMUrAIx4V_Dq5McvAS8c0vmwXUeDCV6fbyg4Ejlf7_3Xz_Tw4sDyv_3b33p5ZYT7lpQPq6A65PSBLOu9V4S65Zpp75ObJEDu_T37P9VjKjLaWzr93tHa0bhA2OlPBLwpgkFYXbuWvVkYayww17Q9Fx3xrlDnsc3unjrYGSyCo5cZR1VTUJ71j9SzjaNdeevEKCwNZ06uaF62bs7qsx3-iVu2qa13tDqiinv8YyySPm7LvgKdv_9GSej7cB2Rx9OHb--NoKOUQlQC4uojnM8sBacxMYpVWmqs0rmzJhTGCFSzReVrGXFnLijQx4GYxwQtbKGN0KXKl04dkr2kb85jQJK_iqsBvNqXILOANnsJ5ozBAWhqVqwk5CNZPrnraDolE2mEL2LTExZe4-JLLgk_IdFzsbT_vJgl2RfIQdSF4u3_QrpdysHpZpLpQZR4rwausSjMF-BTZc1imFQyBTcgL1CTZ33ndbjZyjpxIDJDrbEJeegmk6mgwF2ipNs7Jj1-_BELTQci2MDCY3_5qBUwYsnsFkvuBJOwlOmh-1GvybvAcXE7GoYUHOh6MO2xp6jNPU56AKw9w9Mn_mKin5NaYqBmLfbLXrTfmGaDBrnzuzfwP5P5hBw
  priority: 102
  providerName: Scholars Portal
Title Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study
URI https://www.ncbi.nlm.nih.gov/pubmed/17559672
http://dx.doi.org/10.1186/1471-2407-7-97
https://pubmed.ncbi.nlm.nih.gov/PMC1899509
https://doaj.org/article/93c9ab50a87d4d34a551767564ca9206
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaHhAXxJuFUiyEtKd0k03iR2-7FVVBWoQKlSoukePY24huEjXZQ39j_xQzTrLU4sYlWq3HUZzM47M9_oaQT6EobKoBuUk5twFunAVKWB2ItOBpYlnMXc3I1Td2fpl8vUqv9kg6noVxSfs6L4-rm81xVV673Mpmo2djntjs--o0gkkCBLrZPtkHBR2n6MPWARehGNgZI8FmEXhf3ELgAQ-kK7nHAUQzZAT2TrjfeIHJ8ffvvPQuNvl5kw8C0dlT8mRAkHTRP-kzsmeq5-TRatgjf0HuF3osWUZrSxe_O1q2tKwQHramgF8UQB8t7trGHaEMNJYTquqNomNeNcos-xzeaUtrg6UO1HrbUlUV1CW3Y5Us09KufnDjBgsAWdOrlBMtq-syL8cnUU3ddHVbtidUUcdzjOWQR-frOmCU7RcnqeO9fUkuzz7_PD0PhpINQQ7Aqgt4OrccEMXcRFZppbmKw8LmXBgjmGSRTuM85MpaJuPIwHSKCS6tVMboXKRKx6_IQVVX5g2hUVqEhcS1mVwkFnAFjyGuKNwIzY1K1YSceN8va3p6jgwJs_0WsN0M9SBDPch4JvmETMePvevnpkOC_SO5RF3w7u7-qG_X2aCUmYy1VHkaKsGLpIgTBTgUWXJYohUMgU3IB9SkrD_bunMq2QK5jxgg1PmEfHQSSMlRYc7PWm3bNvvy48ITmg5CtoaBwfvtj1DAC0MWL0_y0JMEn6G95te9Jv8d_GAVE8I9HffG7beAdTo68sEa3_53z3fk8ZiFGYpDctDdbs17gHpdfuSWSOC6SgRcL5a_jpyx_wF75Vx1
link.rule.ids 108,230,315,730,783,787,867,888,2109,2228,24330,24949,27936,27937,53804,53806,76140,76141
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbGkIAXxM9RGMxCSH3KmjSJ7eytm5g6WCcEm7Q3y3HsLmJNqiV94G_kn-LOScos3nir6nMUJ3e-z7m77wj5FIrCphqQW5ZNbYCBs0AJqwORFjxNLIu56xm5uGDzq-TLdXq9Q9KhFsYl7eu8PKxuV4dVeeNyK9crPRnyxCbfFicRHBLA0U0ekIdgr2EyHNL74AEXoej5GSPBJhHsvxhE4AEPMtd0jwOMZsgJ7NW433quyTH4b_fprXfyMyfvuaLTZ-RpjyHprLvX52THVC_Io0UfJX9Jfs_00LSM1pbOfra0bGhZIUBsTAG_KMA-Wvxq1q6IMtDYUKiqV4oOmdUoc9xl8Y4bWhtsdqCWm4aqqqAuvR37ZJmGtvW9C6-xBZA1nVI50bK6KfNyuBO1rtdt3ZTNEVXUMR1jQ-Rh-3UT0M92nyepY759Ra5OP1-ezIO-aUOQA7RqA55OLQdMMTWRVVppruKwsDkXxgiWsUincR5yZS3L4sjAgYoJntlMGaNzkSodvya7VV2ZN4RGaREWGX6dyUViAVnwGDyLwlBoblSqRuTIe39y3RF0SKTM9kfAeiXqgUQ9kFxmfETGw8veznMHIsH-kTxGXfCu7v6o75ayV0uZxTpTeRoqwYukiBMFSBR5cliiFSyBjcgBapLsqlu324qcIfsRA4w6HZGPTgJJOSrM-lmqTdPIsx_fPaFxL2RrWBg8366IAh4Y8nh5kvueJOwa2hve6zT57-J7qxgR7um4t25_BOzTEZL39vj2v2cekMfzy8W5PD-7-PqOPBlyMkOxT3bbu415D8CvzT84M_8DUmtc7Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLdgSBMXxDeFwSyE1FPWpGlsZ7duUG1ApwmYtJvlOHYXsSbRkh74G_mneM9JSi1u3Kr6OYqT9_Fz3vPvEfIhFLlNNCC3NJ3aABNngRJWByLJeTKzLOauZ-Tygp1dzT5fJ9c7rb5c0b7OiqPydn1UFjeutrJe68lQJza5XJ5GsEmAQDepczu5Tx6AzYZs2Kj3CQQuQtFzNEaCTSLwwZhI4AEPUtd4jwOUZsgL7J1zv_XCk2Px3_rqbYTyqyd3wtHiMXnU40g67-73Cblnyqdkf9lnyp-R33M9NC6jlaXzny0tGlqUCBIbk8MvCtCP5r-a2h2kDDQ2FSqrtaJDdTXKnHSVvOOGVgYbHqjVpqGqzKkrccdeWaahbbVz4RrbAFnTKZYTLcqbIiuGO1F1VbdVUzTHVFHHdoxNkQcX7CZgrO0-UVLHfvucXC0-_Tg9C_rGDUEG8KoNeDK1HHDF1ERWaaW5isPcZlwYI1jKIp3EWciVtSyNIwObKiZ4alNljM5EonT8guyVVWleERoleZin-IUmEzML6ILHEF0UpkMzoxI1Isfe-5N1R9IhkTbbHwELlqgHEvVAcpnyERkPL3s7z22KBPtH8gR1wbu6-6O6W8leNWUa61RlSagEz2d5PFOARpErh820giWwETlETZLdCdeta5FzZEBigFOnI_LeSSAxR4mVPyu1aRp5_v2bJzTuhWwFC4Pn2x2kgAeGXF6e5IEnCZ5De8MvO03-u_jeKkaEezrurdsfARt1pOS9Tb7-75mHZP_y40J-Pb_48oY8HMoyQ3FA9tq7jXkL2K_N3jkr_wMZAF4A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Activation+of+Akt+is+increased+in+the+dysplasia-carcinoma+sequence+in+Barrett%27s+oesophagus+and+contributes+to+increased+proliferation+and+inhibition+of+apoptosis%3A+a+histopathological+and+functional+study&rft.jtitle=BMC+cancer&rft.au=El-Amin+Khalid&rft.au=Cameron+Ewen&rft.au=Ogunwobi+Olorunseun&rft.au=Beales+Ian+LP&rft.date=2007-06-08&rft.pub=BMC&rft.issn=1471-2407&rft.eissn=1471-2407&rft.volume=7&rft.issue=1&rft.spage=97&rft_id=info:doi/10.1186%2F1471-2407-7-97&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_93c9ab50a87d4d34a551767564ca9206
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon